Kearns, J.T.; Ashworth, A.; Castro, E.; Eeles, R.A.; FitzGerald, L.M.; Hulick, P.J.; Loeb, S.; Pavlovich, C.P.; Rebbeck, T.R.; Vadaparampil, S.T.;
et al. SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation. Soc. Int. Urol. J. 2025, 6, 45.
https://doi.org/10.3390/siuj6030045
AMA Style
Kearns JT, Ashworth A, Castro E, Eeles RA, FitzGerald LM, Hulick PJ, Loeb S, Pavlovich CP, Rebbeck TR, Vadaparampil ST,
et al. SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation. Société Internationale d’Urologie Journal. 2025; 6(3):45.
https://doi.org/10.3390/siuj6030045
Chicago/Turabian Style
Kearns, James T., Annabelle Ashworth, Elena Castro, Rosalind A. Eeles, Liesel M. FitzGerald, Peter J. Hulick, Stacy Loeb, Christian P. Pavlovich, Timothy R. Rebbeck, Susan T. Vadaparampil,
and et al. 2025. "SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation" Société Internationale d’Urologie Journal 6, no. 3: 45.
https://doi.org/10.3390/siuj6030045
APA Style
Kearns, J. T., Ashworth, A., Castro, E., Eeles, R. A., FitzGerald, L. M., Hulick, P. J., Loeb, S., Pavlovich, C. P., Rebbeck, T. R., Vadaparampil, S. T., Shi, Z., Tran, H., Wei, J., Xu, J., & Helfand, B. T.
(2025). SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation. Société Internationale d’Urologie Journal, 6(3), 45.
https://doi.org/10.3390/siuj6030045
